Alkermes (ALKS) Cash from Operations (2010 - 2026)
Alkermes (ALKS) posted quarterly Cash from Operations of 145183000.0 for Q2 2026, down 3.34% year-over-year from 150202000.0 in Q2 2025, and up 187.6% quarter-over-quarter from 165743000.0 in Q1 2026.
Alkermes (ALKS) Cash from Operations (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Cash from Operations for 17 consecutive years, with 145183000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Operations fell 3.34% year-over-year to 145183000.0; the TTM figure through Jun 2026 stood at 251181000.0 (down 51.79% YoY), while the FY2025 annual figure was 520754000.0, up 18.59% from the prior year.
- Cash from Operations advanced to 145183000.0 in Q2 2026 per ALKS's latest filing, from 165743000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 215710000.0 in Q2 2023 and bottomed at 165743000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 75650833.33 across 5 years, with a median of 99259500.0 in 2023.
- Annual changes were most pronounced in 2023 — Cash from Operations soared 15853.28% — and 2026, when it tumbled 267.74%.
- Alkermes' Cash from Operations stood at 1047000.0 in 2022, then soared by 10142.31% to 107237000.0 in 2023, then jumped by 77.55% to 190397000.0 in 2024, then declined by 10.68% to 170069000.0 in 2025, then slipped by 14.63% to 145183000.0 in 2026.
- Business Quant data shows ALKS's Cash from Operations at 145183000.0 in Q2 2026, 165743000.0 in Q1 2026, and 170069000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 145.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 145.18 Mn |
| Jun 30, 2026 | 145.18 Mn |
| Mar 31, 2026 | -165.74 Mn |
| Mar 31, 2026 | -165.74 Mn |
| Dec 31, 2025 | 170.07 Mn |
| Dec 31, 2025 | 170.07 Mn |
| Sep 30, 2025 | 101.67 Mn |
| Sep 30, 2025 | 101.67 Mn |
| Jun 30, 2025 | 150.20 Mn |
| Jun 30, 2025 | 150.20 Mn |
| Mar 31, 2025 | 98.81 Mn |
| Mar 31, 2025 | 98.81 Mn |
| Dec 31, 2024 | 190.40 Mn |
| Dec 31, 2024 | 190.40 Mn |
| Sep 30, 2024 | 81.59 Mn |
| Sep 30, 2024 | 81.59 Mn |
| Jun 30, 2024 | 146.03 Mn |
| Jun 30, 2024 | 146.03 Mn |
| Mar 31, 2024 | 21.11 Mn |
| Mar 31, 2024 | 21.11 Mn |